Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oil Palm Phenolics Supplementation in Minor Hyperlipidaemia
NCT04573218Phase 2Completed
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms). Primary endpoint: Changes of fasting plasma LDL cholesterol levels at Day 60. Started Oct 2021; status: completed.
Beyond the preview
Go deeper on NCT04573218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04573218.